单扫描仪单协议定量ADC测量与ADC比值检测临床显著前列腺癌的比较
研究纳入259例在单台3T MRI扫描仪行单协议检查后接受MRI-经直肠超声融合活检的患者,比较病灶平均ADC与以正常外周带、移行带、膀胱及闭孔内肌为参考的ADC比值对临床显著前列腺癌(GS≥3+4)的预测能力。平均ADC与Gleason评分相关性最强(ρ=-0.34),平均ADC与ADCratioPZNL的ROC AUC最高(均为0.68),结论为高度标准化的单扫描仪平均ADC测量无法被任何单一ADC比值参数或其组合所改进。
要点
- 临床显著前列腺癌定义为Gleason评分≥3+4。
- 平均ADC与Gleason评分呈负相关,ρ为-0.34,为所有参数中最强。
- 平均ADC与ADCratioPZNL的ROC AUC最高,均为0.68。
核心结论
- 在高度标准化的单扫描仪单协议设置下,平均ADC测量对前列腺癌侵袭性的预测能力无法被任何单一ADC比值参数或其组合所改进。
研究设计与样本
- 回顾性研究纳入284例连续患者,均在同一台3T MRI扫描仪行单协议检查后接受MRI-经直肠超声融合活检。
- 排除既往接受治疗者后,最终队列259例,其中220例共351个MR病灶。
- 由一名委员会认证的放射科医生在不知临床信息的情况下回顾所有MRI,在全部局灶性病变及以下参考区放置感兴趣区:正常表现外周带(PZNL)、正常表现移行带(TZNL)、膀胱(BLA)、右侧闭孔内肌(RIOM)和左侧闭孔内肌(LIOM)。
- 主要终点为临床显著前列腺癌,定义为Gleason评分≥3+4;采用Spearman秩相关系数、单变量和多变量逻辑回归、ROC曲线及DeLong检验比较AUC。
- 偏倚校正AUC值及相应95%CI通过100次bootstrap抽样计算。
诊断标准与关键数值
- 临床显著前列腺癌定义为Gleason评分≥3+4。
- 平均ADC与Gleason评分相关性最强,ρ=-0.34;ADCratioPZNL次之,ρ=-0.32。
- 除ADCratioLIOM(P=0.07)外,所有ADC参数均与临床显著前列腺癌相关(P<0.05)。
- 平均ADC与ADCratioPZNL的ROC AUC最高,均为0.68。
- 包含平均ADC的多变量模型可改善预测性能。
临床应用与阅片要点
- 在单扫描仪单协议设置下,可依据病灶平均ADC预测临床显著前列腺癌,其与Gleason评分的相关性优于各ADC比值参数。
- 以正常外周带为参考的ADC比值(ADCratioPZNL)预测性能与平均ADC相当,AUC均为0.68。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Mean ADC has high predictive value for the presence of clinically significant prostate cancer (sPC). Measurement variability is introduced by different scanners, protocols, intra-and inter-patient variation. Internal calibration by ADC ratios can address such fluctuations however can potentially lower the biological value of quantitative ADC determination by being sensitive to deviations in reference tissue signal.
PURPOSE: To better understand the predictive value of quantitative ADC measurements in comparison to internal reference ratios when measured in a single scanner, single protocol setup.
MATERIALS AND METHODS: 284 consecutive patients who underwent 3 T MRI on a single scanner followed by MRI-transrectal ultrasound fusion biopsy were included. A board-certified radiologist retrospectively reviewed all MRIs blinded to clinical information and placed regions of interest (ROI) on all focal lesions and the following reference regions: normal-appearing peripheral zone (PZNL) and transition zone (TZNL), the urinary bladder (BLA), and right and left internal obturator muscle (RIOM, LIOM). ROI-based mean ADC and ADC ratios to the reference regions were compared regarding their ability to predict the aggressiveness of prostate cancer. Spearman's rank correlation coefficient was used to estimate the correlation between ADC parameters, Gleason score (GS) and ADC ratios. The primary endpoint was presence of sPC, defined as a GS ≥ 3 + 4. Univariable and multivariable logistic regression models were constructed to predict sPC. Receiver operating characteristics curves (ROC) were used for visualization; DeLong test was used to evaluate the differences of the area under the curve (AUC). Bias-corrected AUC values and corresponding 95 %-CI were calculated using bootstrapping with 100 bootstrap samples.
RESULTS: After exclusion of patients who received prior treatment, 259 patients were included in the final cohort of which 220 harbored 351 MR lesions. Mean ADC and ADC ratios demonstrated a negative correlation with the GS. Mean ADC had the strongest correlation with ρ of -0.34, followed by ADCratioPZNL (ρ=-0.32). All ADC parameters except ADCratioLIOM (p = 0.07) were associated with sPC p<0.05). Mean ADC and ADCratioPZNL had the highest ROC AUC of all parameters (0.68). Multivariable models with mean ADC improve predictive performance.
CONCLUSIONS: A highly standardized single-scanner mean ADC measurement could not be improved upon using any of the single ADC ratio parameters or combinations of these parameters in predicting the aggressiveness of prostate cancer.
引用
- Wang X, Hielscher T, Radtke JP, et al. Comparison of single-scanner single-protocol quantitative ADC measurements to ADC ratios to detect clinically significant prostate cancer. Eur J Radiol. 2021. PMID: 33482592. doi:10.1016/j.ejrad.2021.109538
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。